| Primary |
| Breast Cancer |
75.0% |
| Product Used For Unknown Indication |
25.0% |
|
| White Blood Cell Count Increased |
100.0% |
|
| Secondary |
| Hodgkin's Disease |
21.5% |
| Product Used For Unknown Indication |
20.0% |
| Breast Cancer |
12.9% |
| Bone Marrow Conditioning Regimen |
6.9% |
| Diffuse Large B-cell Lymphoma |
4.3% |
| Peripheral T-cell Lymphoma Unspecified |
3.6% |
| Plasma Cell Myeloma |
2.9% |
| Primitive Neuroectodermal Tumour |
2.9% |
| Allogenic Bone Marrow Transplantation Therapy |
2.6% |
| Chronic Lymphocytic Leukaemia |
2.6% |
| Burkitt's Lymphoma |
2.4% |
| Invasive Ductal Breast Carcinoma |
2.4% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Non-hodgkin's Lymphoma |
2.1% |
| Stem Cell Transplant |
2.1% |
| T-cell Lymphoma |
2.1% |
| Sarcoma Metastatic |
1.9% |
| Acute Myeloid Leukaemia |
1.7% |
| Aesthesioneuroblastoma |
1.7% |
| Angioimmunoblastic T-cell Lymphoma |
1.2% |
|
| Blood Luteinising Hormone Increased |
18.8% |
| Venoocclusive Liver Disease |
10.1% |
| White Blood Cell Count Decreased |
8.7% |
| Neutropenia |
7.2% |
| Rash |
5.8% |
| Toxicity To Various Agents |
5.8% |
| Blood Follicle Stimulating Hormone Increased |
4.3% |
| Febrile Neutropenia |
4.3% |
| Vomiting |
4.3% |
| Gastrointestinal Infection |
2.9% |
| Infection |
2.9% |
| Maternal Drugs Affecting Foetus |
2.9% |
| Metastases To Liver |
2.9% |
| Ovarian Failure |
2.9% |
| Platelet Count Decreased |
2.9% |
| Renal Failure Acute |
2.9% |
| Thrombocytopenia |
2.9% |
| Viral Haemorrhagic Cystitis |
2.9% |
| Weight Decreased |
2.9% |
| Acute Myeloid Leukaemia |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.4% |
| Plasma Cell Myeloma |
18.5% |
| Burkitt's Lymphoma |
8.3% |
| Breast Cancer |
5.6% |
| Immunosuppression |
5.6% |
| Bone Marrow Conditioning Regimen |
4.6% |
| Stem Cell Transplant |
4.6% |
| Alveolar Rhabdomyosarcoma |
3.7% |
| Prophylaxis |
3.7% |
| Waldenstrom's Macroglobulinaemia |
3.7% |
| Invasive Ductal Breast Carcinoma |
2.8% |
| Lymphoma |
2.8% |
| Prophylaxis Against Graft Versus Host Disease |
2.8% |
| Ulcer |
2.8% |
| Breast Cancer Stage Ii |
1.9% |
| Convulsion |
1.9% |
| Immune Tolerance Induction |
1.9% |
| Myeloid Leukaemia |
1.9% |
| Neuromyelitis Optica |
1.9% |
| Non-hodgkin's Lymphoma |
1.9% |
|
| White Blood Cell Count Decreased |
15.0% |
| Stomatitis |
10.0% |
| Tremor |
7.5% |
| Cystitis Haemorrhagic |
5.0% |
| Cytomegalovirus Infection |
5.0% |
| Death |
5.0% |
| Disease Progression |
5.0% |
| Milk Allergy |
5.0% |
| Pericardial Effusion |
5.0% |
| Rash |
5.0% |
| Renal Failure Acute |
5.0% |
| Thrombocytopenia |
5.0% |
| Urinary Incontinence |
5.0% |
| Arteriospasm Coronary |
2.5% |
| Bacterial Sepsis |
2.5% |
| Cardiomyopathy |
2.5% |
| Complications Of Transplant Surgery |
2.5% |
| Drug Ineffective |
2.5% |
| Full Blood Count Decreased |
2.5% |
| Functional Gastrointestinal Disorder |
2.5% |
|
